Palisade Bio, Inc.
PALI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $3 | $3 | $10 |
| - Cash | $5 | $5 | $7 | $10 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | -$2 | -$4 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$3 | -$2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$2 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.38 | -0.58 | -0.46 | -0.39 |
| % Growth | 34.5% | -26.1% | -17.9% | – |
| Operating Cash Flow | -$4 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$2 | -$2 | -$2 |